Difco Products;Serum & Medium ישראל - עברית - Ministry of Health

difco products;serum & medium

"ע.לפידות פרמצויטיקלס בע""מ " - צוות טכני - גידול וזיהוי חיידקים

Difco Products;Serum & Medium ישראל - עברית - Ministry of Health

difco products;serum & medium

ע.לפידות פרמצויטיקלס בע"מ - צוות טכני - גידול וזיהוי חיידקים

טריויד 200 מ"ג תמיסה לאינפוזיה תוך ורידית ישראל - עברית - Ministry of Health

טריויד 200 מ"ג תמיסה לאינפוזיה תוך ורידית

sanofi - aventis israel ltd - ofloxacin 2 mg/ml - solution for infusion - ofloxacin - infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. prevention of infections in patients with a signifcant reduction of resistance to infections,

אופלוקסצינה ישראל - עברית - Ministry of Health

אופלוקסצינה

bioavenir ltd, israel - ofloxacin as hydrochloride - תמיסה לאינפוזיה - ofloxacin as hydrochloride 2 mg/ml - ofloxacin - ofloxacin - infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. prevention of infections in patients with a signifcant reduction of resistance to infections.

לורמיקס 200 מג ישראל - עברית - Ministry of Health

לורמיקס 200 מג

megapharm ltd - rifaximine - טבליות מצופות פילם - rifaximine 200 mg - rifaximin - rifaximin - • casual treatment of diseases of grown-ups and youngsters from 12 years up, caused by bacteria in the gastrointestinal tract, sensitive to rifaximin:• hepatic encephalopathy • traveller’s diarrhea, caused by not-invasive enteropathogeneous bacteria

מיקובוטין ישראל - עברית - Ministry of Health

מיקובוטין

pfizer pfe pharmaceuticals israel ltd - rifabutin - קפסולות - rifabutin 150 mg - rifabutin - rifabutin - for the treatment of chronic tuberculosis where there is evidence of acid fast bacteria resistant to rifampicin or to two other alternative drugs. for the treatment of infections caused by mac or other atypical mycobacteria where there is evidence of resistant bacteria as above. for the treatment of infections caused by mac or other atypical mycobacteria in aids patients in all cases not subject to the above restrictions. for prevention of mac infections in aids patients whose cd4 counts lower or eqval to 200/mm3

מפקט ישראל - עברית - Ministry of Health

מפקט

takeda israel ltd - mifamurtide - powder for suspension for infusion - mifamurtide 4 mg/vial - mifamurtide - mifamurtide - mepact is indicated in children, adolescents and young adults for the treatment of high grade resectable non metastatic osteosarcoma after macroscopically complete surgical resection. it is used in combination with post operative multi-agent chemotherapy. safety and efficacy have been assessed in studies of patients 2 to 30 years of age at initial diagnosis.

מפקט ישראל - עברית - Ministry of Health

מפקט

takeda israel ltd - mifamurtide - mifamurtide 4 mg/vial - mifamurtide